Early effects of lasonolide a on pancreatic cancer cells.
Lasonolide A, a novel polyketide-derived macrolide, was previously identified from an extract of the marine sponge Forcepia sp. in an assay for protein kinase C (PKC) inhibitors. Cytotoxicity testing and profiling of lasonolide A in the National Cancer Institute (NCI) 60 cell panel screen revealed that it was potent toward a broad range of cell lines and also suggested a unique mechanism of action. Contrary to expected results, we found lasonolide A to be a strong activator of PKC in Panc-1 pancreatic carcinoma cells. Downstream mitogen-activated protein kinases, ERK 1/2 and p38 were also rapidly phosphorylated in response to lasonolide A, as was Akt. Microscopy studies revealed that lasonolide A induced blebbing and contraction of the cells within minutes of exposure, and the eventual loss of adherence. However, membrane integrity was maintained and the effects were reversible if lasonolide A was washed from the cells after their loss of adherence. Pretreatment of cells with a myosin II inhibitor, blebbistatin, slowed the early onset, but did not prevent the morphological effects of lasonolide A. Cells stained for actin filaments showed some reduction in stress fiber structure after lasonolide A exposure; however, it did not affect the polymerization of purified actin in vitro. Bisindolemaleimide, a PKC inhibitor, and wortmannin, a phosphoinositide 3-kinase; inhibitor, did not reduce lasonolide A-induced contraction or blebbing or the activation of mitogen-activated protein kinases, although Akt phosphorylation was prevented by wortmannin pretreatment. Our results indicate that lasonolide A activates multiple signal transduction pathways and suggest that the origin is upstream of PKC.
Isbrucker
Richard A
RA
Harbor Branch Oceanographic Institute at Florida Atlantic University, Center for Marine Biomedical and BiotechnologyResearch, Fort Pierce, Florida 34946, USA.
Guzmán
Esther A
EA
Pitts
Tara P
TP
Wright
Amy E
AE
D000199:Actins / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000187:drug effects / Q000648:ultrastructure; D002470:Cell Survival / Q000187:drug effects; D003599:Cytoskeleton / Q000187:drug effects; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D018942:Macrolides / Q000494:pharmacology*; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010766:Phosphorylation; D011161:Porifera / Q000737:chemistry; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects; D013778:Tetrazolium Salts; D013844:Thiazoles; D014404:Tubulin / Q000378:metabolism
D000199:Actins; D018942:Macrolides; D047428:Protein Kinase Inhibitors; D013778:Tetrazolium Salts; D013844:Thiazoles; D014404:Tubulin; C450700:lasonolide A; D007770:L-Lactate Dehydrogenase; D011493:Protein Kinase C; D020928:Mitogen-Activated Protein Kinases; C022616:thiazolyl blue
J Cell Sci. 1993 Aug;105 ( Pt 4):883-90
8227210
FASEB J. 2004 Mar;18(3):592-4
14734633
J Antibiot (Tokyo). 1991 Jan;44(1):93-102
2001987
J Nat Prod. 2004 Aug;67(8):1351-5
15332854
Methods Enzymol. 1982;85 Pt B:182-210
6889668
Nat Rev Cancer. 2006 Oct;6(10):813-23
16990858
Cell Signal. 2006 Mar;18(3):276-84
16109477
Biochim Biophys Acta. 2002 Apr 3;1589(2):93-103
12007785
Cell Mol Life Sci. 2006 Sep;63(18):2119-34
16909206
Microsc Res Tech. 1999 Oct 1;47(1):18-37
10506759
Cell Mol Life Sci. 2008 Nov;65(22):3525-44
18668205
Science. 2003 Mar 14;299(5613):1743-7
12637748
Angew Chem Int Ed Engl. 2003 Oct 13;42(39):4779-82
14562347
Biochem Pharmacol. 2003 Jul 1;66(1):75-82
12818367
J Biol Chem. 2004 Aug 20;279(34):35557-63
15205456
J Cell Physiol. 2007 Dec;213(3):589-602
17786953
Cancer Res. 1988 Feb 1;48(3):589-601
3335022
Pancreas. 2004 Apr;28(3):353-8
15084985
J Muscle Res Cell Motil. 2004;25(4-5):337-41
15548862
J Antibiot (Tokyo). 1988 Jul;41(7):925-31
3138226
Org Lett. 2006 Feb 2;8(3):475-8
16435863
Chem Asian J. 2008 Oct 6;3(10):1811-23
18712746
J Natl Cancer Inst. 1989 Jul 19;81(14):1088-92
2738938
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13851-6
14612571